ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "What's Wrong With The UK Extended Access Program?"
Episode Synopsis
The extended access scheme allows patients to have early access to drugs which are not approved on the market but have shown potential in clinical trials. In the UK for the last 10 years were treated over 1,200 patients while in the USA just in 2022 were treated 2,417 patients. Why is that difference? You can learn more from this episode and what could be done to improve access to medications to more patients in the UK.
In God we trust